Status:
RECRUITING
Register Study: Implementation of Pharyngeal Electrostimulation Therapy for the Treatment of Acute Neurogenic Dysphagia
Lead Sponsor:
Karl Landsteiner University of Health Sciences
Collaborating Sponsors:
Universitätsklinikum Tulln
Conditions:
Neurogenic Dysphagia
Traumatic Brain Injury
Eligibility:
All Genders
18+ years
Brief Summary
Neurogenic dysphagia occurs with disruption of neurological systems or processes involved in the execution of coordinated and safe swallowing. It is common in patients with neurological diseases, in p...
Detailed Description
Neurogenic dysphagia occurs with disruption of neurological systems or processes involved in the execution of coordinated and safe swallowing. It is common in patients with neurological diseases, in p...
Eligibility Criteria
Inclusion
- Neurogenic dysphagia
- Ischaemic and haemorrhagic strokes
- Infra- as well as supra-tentorial
- Polyradiculitis
- Parkinson's disease
- Multiple sclerosis
- Dementia
- Traumatic brain injury
- Post Covid-19 pat.
- patients over the age of 18.
Exclusion
- Contraindication to nasogastric tube,
- Unstable cardiac or respiratory condition that does not allow the insertion of the Nasogastric tube
- Pacemakers
- Implanted defibrillators (ICD)
- Pregnant
- Breastfeeding women
- (Caution: interfering signals may be visible in ECGs, \& EEGs with continuous recording).
Key Trial Info
Start Date :
December 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05190718
Start Date
December 15 2021
End Date
December 30 2026
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Tulln
Tulln, Low Austria, Austria, 3430